nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—Parkinson's disease	0.446	0.57	CbGaD
Naratriptan—HTR1A—Parkinson's disease	0.337	0.43	CbGaD
Naratriptan—MAOA—locus ceruleus—Parkinson's disease	0.00768	0.114	CbGeAlD
Naratriptan—HTR1B—telencephalic ventricle—Parkinson's disease	0.00494	0.0736	CbGeAlD
Naratriptan—HTR1D—telencephalic ventricle—Parkinson's disease	0.00478	0.0712	CbGeAlD
Naratriptan—HTR1A—telencephalic ventricle—Parkinson's disease	0.00399	0.0594	CbGeAlD
Naratriptan—HTR1F—forebrain—Parkinson's disease	0.00315	0.0469	CbGeAlD
Naratriptan—MAOA—nerve—Parkinson's disease	0.0023	0.0342	CbGeAlD
Naratriptan—HTR1A—hindbrain—Parkinson's disease	0.00188	0.028	CbGeAlD
Naratriptan—HTR1F—head—Parkinson's disease	0.0018	0.0269	CbGeAlD
Naratriptan—MAOA—hindbrain—Parkinson's disease	0.00172	0.0256	CbGeAlD
Naratriptan—HTR1F—nervous system—Parkinson's disease	0.00171	0.0255	CbGeAlD
Naratriptan—HTR1F—central nervous system—Parkinson's disease	0.00165	0.0245	CbGeAlD
Naratriptan—HTR1B—brainstem—Parkinson's disease	0.00134	0.0199	CbGeAlD
Naratriptan—HTR1F—brain—Parkinson's disease	0.00131	0.0195	CbGeAlD
Naratriptan—HTR1D—brainstem—Parkinson's disease	0.00129	0.0193	CbGeAlD
Naratriptan—HTR1B—forebrain—Parkinson's disease	0.00129	0.0192	CbGeAlD
Naratriptan—HTR1D—forebrain—Parkinson's disease	0.00125	0.0186	CbGeAlD
Naratriptan—HTR1B—cardiovascular system—Parkinson's disease	0.00109	0.0162	CbGeAlD
Naratriptan—HTR1A—brainstem—Parkinson's disease	0.00108	0.0161	CbGeAlD
Naratriptan—MAOA—embryo—Parkinson's disease	0.00108	0.016	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—Parkinson's disease	0.00106	0.0157	CbGeAlD
Naratriptan—HTR1A—forebrain—Parkinson's disease	0.00104	0.0155	CbGeAlD
Naratriptan—Almotriptan—MAOA—Parkinson's disease	0.00102	0.15	CrCbGaD
Naratriptan—MAOA—brainstem—Parkinson's disease	0.000986	0.0147	CbGeAlD
Naratriptan—Sumatriptan—MAOA—Parkinson's disease	0.000985	0.145	CrCbGaD
Naratriptan—MAOA—forebrain—Parkinson's disease	0.000951	0.0142	CbGeAlD
Naratriptan—HTR1A—cardiovascular system—Parkinson's disease	0.000881	0.0131	CbGeAlD
Naratriptan—HTR1B—midbrain—Parkinson's disease	0.000852	0.0127	CbGeAlD
Naratriptan—HTR1B—spinal cord—Parkinson's disease	0.000831	0.0124	CbGeAlD
Naratriptan—HTR1D—midbrain—Parkinson's disease	0.000825	0.0123	CbGeAlD
Naratriptan—MAOA—cardiovascular system—Parkinson's disease	0.000805	0.012	CbGeAlD
Naratriptan—Eletriptan—HTR7—Parkinson's disease	0.000785	0.115	CrCbGaD
Naratriptan—Sumatriptan—HTR1A—Parkinson's disease	0.000744	0.109	CrCbGaD
Naratriptan—HTR1B—head—Parkinson's disease	0.000739	0.011	CbGeAlD
Naratriptan—HTR1D—head—Parkinson's disease	0.000715	0.0107	CbGeAlD
Naratriptan—HTR1B—nervous system—Parkinson's disease	0.000701	0.0104	CbGeAlD
Naratriptan—HTR1A—midbrain—Parkinson's disease	0.000688	0.0102	CbGeAlD
Naratriptan—MAOA—medulla oblongata—Parkinson's disease	0.000687	0.0102	CbGeAlD
Naratriptan—HTR1D—nervous system—Parkinson's disease	0.000678	0.0101	CbGeAlD
Naratriptan—HTR1B—central nervous system—Parkinson's disease	0.000675	0.01	CbGeAlD
Naratriptan—HTR1A—spinal cord—Parkinson's disease	0.000671	0.00999	CbGeAlD
Naratriptan—HTR1D—central nervous system—Parkinson's disease	0.000653	0.00972	CbGeAlD
Naratriptan—Sumatriptan—DRD2—Parkinson's disease	0.000631	0.0928	CrCbGaD
Naratriptan—Almotriptan—CYP2E1—Parkinson's disease	0.000631	0.0928	CrCbGaD
Naratriptan—MAOA—midbrain—Parkinson's disease	0.000628	0.00935	CbGeAlD
Naratriptan—MAOA—spinal cord—Parkinson's disease	0.000613	0.00913	CbGeAlD
Naratriptan—Eletriptan—HTR1A—Parkinson's disease	0.000602	0.0885	CrCbGaD
Naratriptan—HTR1A—head—Parkinson's disease	0.000596	0.00888	CbGeAlD
Naratriptan—HTR1A—nervous system—Parkinson's disease	0.000565	0.00842	CbGeAlD
Naratriptan—MAOA—head—Parkinson's disease	0.000545	0.00811	CbGeAlD
Naratriptan—HTR1A—central nervous system—Parkinson's disease	0.000544	0.0081	CbGeAlD
Naratriptan—HTR1B—brain—Parkinson's disease	0.000535	0.00797	CbGeAlD
Naratriptan—HTR1A—cerebellum—Parkinson's disease	0.000532	0.00792	CbGeAlD
Naratriptan—HTR1D—brain—Parkinson's disease	0.000518	0.00772	CbGeAlD
Naratriptan—MAOA—nervous system—Parkinson's disease	0.000516	0.00769	CbGeAlD
Naratriptan—MAOA—central nervous system—Parkinson's disease	0.000497	0.0074	CbGeAlD
Naratriptan—MAOA—cerebellum—Parkinson's disease	0.000486	0.00724	CbGeAlD
Naratriptan—Almotriptan—CYP2D6—Parkinson's disease	0.000463	0.0681	CrCbGaD
Naratriptan—HTR1A—brain—Parkinson's disease	0.000432	0.00643	CbGeAlD
Naratriptan—MAOA—brain—Parkinson's disease	0.000395	0.00588	CbGeAlD
Naratriptan—Eletriptan—CYP2D6—Parkinson's disease	0.000361	0.0531	CrCbGaD
Naratriptan—Sumatriptan—ABCB1—Parkinson's disease	0.000319	0.0468	CrCbGaD
Naratriptan—Eletriptan—ABCB1—Parkinson's disease	0.000258	0.0379	CrCbGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD3—Parkinson's disease	6.85e-05	0.000477	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—GRM5—Parkinson's disease	6.85e-05	0.000477	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DGKQ—Parkinson's disease	6.85e-05	0.000477	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GPR37—Parkinson's disease	6.85e-05	0.000477	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PDYN—Parkinson's disease	6.83e-05	0.000476	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—DRD2—Parkinson's disease	6.82e-05	0.000475	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR7—Parkinson's disease	6.82e-05	0.000475	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TAC1—Parkinson's disease	6.71e-05	0.000467	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DGKQ—Parkinson's disease	6.7e-05	0.000467	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GPR37—Parkinson's disease	6.7e-05	0.000467	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PDYN—Parkinson's disease	6.69e-05	0.000466	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD1—Parkinson's disease	6.58e-05	0.000458	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GRK5—Parkinson's disease	6.55e-05	0.000456	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GRM4—Parkinson's disease	6.47e-05	0.000451	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.45e-05	0.000449	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.43e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—ADRBK1—Parkinson's disease	6.4e-05	0.000446	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD3—Parkinson's disease	6.37e-05	0.000444	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—GRM5—Parkinson's disease	6.35e-05	0.000442	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PDYN—Parkinson's disease	6.31e-05	0.000439	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PPP1R1B—Parkinson's disease	6.26e-05	0.000436	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—GRM5—Parkinson's disease	6.22e-05	0.000433	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD2—Parkinson's disease	6.2e-05	0.000432	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR7—Parkinson's disease	6.2e-05	0.000432	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	6.18e-05	0.000431	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—EDN1—Parkinson's disease	6.18e-05	0.000431	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VPS35—Parkinson's disease	6.16e-05	0.000429	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PENK—Parkinson's disease	6.13e-05	0.000427	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PPP1R1B—Parkinson's disease	6.13e-05	0.000427	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—FBP1—Parkinson's disease	6.11e-05	0.000425	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GBA—Parkinson's disease	6.11e-05	0.000425	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DBH—Parkinson's disease	6.11e-05	0.000425	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	6.06e-05	0.000422	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—EDN1—Parkinson's disease	6.05e-05	0.000422	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.95e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GFAP—Parkinson's disease	5.93e-05	0.000413	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GRM4—Parkinson's disease	5.88e-05	0.000409	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GRM5—Parkinson's disease	5.87e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.82e-05	0.000405	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR7—Parkinson's disease	5.76e-05	0.000401	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD2—Parkinson's disease	5.76e-05	0.000401	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PDYN—Parkinson's disease	5.61e-05	0.000391	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PENK—Parkinson's disease	5.57e-05	0.000388	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.48e-05	0.000382	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RIT2—Parkinson's disease	5.47e-05	0.000381	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.47e-05	0.000381	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—EDN1—Parkinson's disease	5.46e-05	0.00038	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2A—Parkinson's disease	5.41e-05	0.000377	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADORA2A—Parkinson's disease	5.4e-05	0.000376	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RIT2—Parkinson's disease	5.36e-05	0.000373	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	5.3e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2A—Parkinson's disease	5.3e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADORA2A—Parkinson's disease	5.29e-05	0.000368	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	5.22e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GRK5—Parkinson's disease	5.19e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR1A—Parkinson's disease	5.16e-05	0.000359	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGF20—Parkinson's disease	5.14e-05	0.000358	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	5.11e-05	0.000356	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	5.11e-05	0.000356	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	5.1e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TAC1—Parkinson's disease	5.08e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GRK5—Parkinson's disease	5.08e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR1A—Parkinson's disease	5.05e-05	0.000352	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADORA2A—Parkinson's disease	4.99e-05	0.000347	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD1—Parkinson's disease	4.98e-05	0.000347	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TAC1—Parkinson's disease	4.98e-05	0.000346	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EDN1—Parkinson's disease	4.96e-05	0.000346	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD1—Parkinson's disease	4.88e-05	0.00034	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD3—Parkinson's disease	4.83e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2A—Parkinson's disease	4.78e-05	0.000333	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	4.74e-05	0.00033	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD3—Parkinson's disease	4.73e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR1A—Parkinson's disease	4.69e-05	0.000326	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.68e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	4.67e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GRM4—Parkinson's disease	4.65e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TAC1—Parkinson's disease	4.61e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	4.61e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INSR—Parkinson's disease	4.6e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR1A—Parkinson's disease	4.59e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GRM4—Parkinson's disease	4.56e-05	0.000317	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD1—Parkinson's disease	4.52e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TAC1—Parkinson's disease	4.52e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.51e-05	0.000314	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DDC—Parkinson's disease	4.48e-05	0.000312	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.44e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD1—Parkinson's disease	4.43e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.41e-05	0.000307	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PENK—Parkinson's disease	4.41e-05	0.000307	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAG—Parkinson's disease	4.41e-05	0.000307	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD3—Parkinson's disease	4.38e-05	0.000305	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR7—Parkinson's disease	4.36e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD2—Parkinson's disease	4.36e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGB—Parkinson's disease	4.35e-05	0.000303	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2A—Parkinson's disease	4.34e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR1A—Parkinson's disease	4.33e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAG—Parkinson's disease	4.32e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PENK—Parkinson's disease	4.32e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD3—Parkinson's disease	4.29e-05	0.000299	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD2—Parkinson's disease	4.27e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR7—Parkinson's disease	4.27e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TAC1—Parkinson's disease	4.26e-05	0.000297	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTA4—Parkinson's disease	4.23e-05	0.000295	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD1—Parkinson's disease	4.18e-05	0.000291	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADRBK1—Parkinson's disease	4.09e-05	0.000285	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	4.08e-05	0.000284	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD3—Parkinson's disease	4.05e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDYN—Parkinson's disease	4.04e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	4.03e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	4.03e-05	0.00028	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADRBK1—Parkinson's disease	4.01e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.98e-05	0.000277	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD2—Parkinson's disease	3.96e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR7—Parkinson's disease	3.96e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDYN—Parkinson's disease	3.95e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD2—Parkinson's disease	3.88e-05	0.00027	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR7—Parkinson's disease	3.88e-05	0.00027	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	3.87e-05	0.00027	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PLA2G6—Parkinson's disease	3.81e-05	0.000265	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GFAP—Parkinson's disease	3.79e-05	0.000264	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	3.79e-05	0.000264	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADRBK1—Parkinson's disease	3.78e-05	0.000263	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.78e-05	0.000263	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MAOB—Parkinson's disease	3.77e-05	0.000263	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GRM5—Parkinson's disease	3.75e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	3.72e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GFAP—Parkinson's disease	3.71e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GRM5—Parkinson's disease	3.67e-05	0.000256	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR7—Parkinson's disease	3.66e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD2—Parkinson's disease	3.66e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	3.6e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—EDN1—Parkinson's disease	3.49e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	3.47e-05	0.000242	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	3.44e-05	0.00024	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—EDN1—Parkinson's disease	3.42e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	3.38e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.36e-05	0.000234	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PENK—Parkinson's disease	3.29e-05	0.000229	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAG—Parkinson's disease	3.29e-05	0.000229	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGF20—Parkinson's disease	3.29e-05	0.000229	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	3.27e-05	0.000228	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	3.26e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	3.26e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGF20—Parkinson's disease	3.22e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.21e-05	0.000223	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADORA2A—Parkinson's disease	3.19e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EDN1—Parkinson's disease	3.17e-05	0.000221	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADORA2A—Parkinson's disease	3.12e-05	0.000217	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EDN1—Parkinson's disease	3.11e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF2—Parkinson's disease	3.07e-05	0.000214	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—Parkinson's disease	3.06e-05	0.000213	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.05e-05	0.000213	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	3.01e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	2.99e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1R—Parkinson's disease	2.97e-05	0.000207	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.96e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.96e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INSR—Parkinson's disease	2.94e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EDN1—Parkinson's disease	2.93e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INSR—Parkinson's disease	2.88e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	2.83e-05	0.000197	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP2D6—Parkinson's disease	2.81e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	2.8e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGB—Parkinson's disease	2.78e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—Parkinson's disease	2.78e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1A—Parkinson's disease	2.77e-05	0.000193	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CTGF—Parkinson's disease	2.75e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	2.73e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGB—Parkinson's disease	2.72e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	2.72e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	2.71e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGF—Parkinson's disease	2.69e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	2.67e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	2.67e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	2.62e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.61e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	2.59e-05	0.00018	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP2E1—Parkinson's disease	2.57e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—Parkinson's disease	2.56e-05	0.000179	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NQO1—Parkinson's disease	2.54e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	2.53e-05	0.000177	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TH—Parkinson's disease	2.5e-05	0.000174	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	2.45e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	2.42e-05	0.000168	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYCS—Parkinson's disease	2.4e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—Parkinson's disease	2.38e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.38e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	2.37e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	2.37e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	2.34e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	2.34e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	2.29e-05	0.00016	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	2.29e-05	0.00016	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.28e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INSR—Parkinson's disease	2.2e-05	0.000153	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—COMT—Parkinson's disease	2.13e-05	0.000148	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTP1—Parkinson's disease	2.12e-05	0.000147	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HMOX1—Parkinson's disease	2.09e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGB—Parkinson's disease	2.08e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	2.07e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—Parkinson's disease	2.04e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	2.03e-05	0.000142	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCB1—Parkinson's disease	2e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.99e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	1.96e-05	0.000137	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTM1—Parkinson's disease	1.94e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.93e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.92e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	1.9e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	1.87e-05	0.000131	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPX1—Parkinson's disease	1.86e-05	0.00013	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.86e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.84e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.8e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.75e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.75e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGF—Parkinson's disease	1.72e-05	0.00012	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—Parkinson's disease	1.72e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.69e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	1.64e-05	0.000114	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.61e-05	0.000112	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—Parkinson's disease	1.6e-05	0.000111	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—Parkinson's disease	1.52e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	1.52e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	1.51e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1.49e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.46e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.41e-05	9.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.4e-05	9.74e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	1.39e-05	9.7e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—Parkinson's disease	1.37e-05	9.52e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—Parkinson's disease	1.3e-05	9.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.28e-05	8.95e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—Parkinson's disease	1.28e-05	8.88e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.22e-05	8.52e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—Parkinson's disease	1.14e-05	7.92e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—Parkinson's disease	9.71e-06	6.76e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	9.7e-06	6.75e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	9.63e-06	6.71e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	9.49e-06	6.61e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	9.43e-06	6.57e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	8.91e-06	6.21e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—Parkinson's disease	8.9e-06	6.2e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	8.73e-06	6.08e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	7.23e-06	5.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	7.19e-06	5e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	6.65e-06	4.63e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—Parkinson's disease	5.69e-06	3.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—Parkinson's disease	5.57e-06	3.88e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—Parkinson's disease	4.24e-06	2.96e-05	CbGpPWpGaD
